| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8726970 | Gastroenterology | 2018 | 33 Pages |
Abstract
Based on systematic and selectively focused review and the consensus of a multidisciplinary panel, we have provided summary information and guidelines for the use of central neuromodulators in the treatment of chronic gastrointestinal symptoms and FGIDs. Further studies are needed to confirm and refine these recommendations.
Keywords
SNRI5-HTCVSEPSNBSFGIDTCAIBS-DPDS5-hydroxytryptamineIBSIBS-CFunctional gastrointestinal disorderFunctional dyspepsiaFunctional gastrointestinal disordersAntidepressantsAntipsychoticsTricyclic antidepressantChronic abdominal painCognitive behavioral therapyCNSGastrointestinalDopamineCBTCyclic vomiting syndromePostprandial Distress Syndromeirritable bowel syndrome with diarrheairritable bowel syndrome with constipationirritable bowel syndromecentral nervous systemSelective serotonin reuptake inhibitorSSRInoradrenalin
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Douglas A. Drossman, Jan Tack, Alexander C. Ford, Eva Szigethy, Hans Törnblom, Lukas Van Oudenhove,